FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009013307> ?p ?o ?g. }

• W3009013307 endingPage "598" @default.
• W3009013307 startingPage "588" @default.
• W3009013307 abstract "Background: Currently, there are limited nonoperative treatment options available for knee osteoarthritis (OA). Cell-based therapies have emerged as promising treatments for knee OA. Autologous stromal vascular fraction (SVF) has been identified as an efficient medium for intra-articular administration of progenitor cells and mesenchymal stem cells derived from adipose tissue. Hypothesis: Patients receiving intra-articular SVF would show significantly greater improvement than patients receiving placebo injections, and this improvement would be dose dependent. Study Design: Randomized controlled trial; Level of evidence, 1. Methods: This was a multisite prospective double-blinded randomized placebo-controlled clinical trial. Adult patients with symptomatic knee OA were eligible. Thirty-nine patients were randomized to high-dose SVF, low-dose SVF, or placebo (1:1:1). SVF was obtained via liposuction, processed to create the cellular implant, and injected during the same clinical visit. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores and magnetic resonance images were obtained preoperatively and at 6 and 12 months after injection. The Wilcoxon rank sum nonparametric test was utilized to assess statistical significance, and the Hodges-Lehmann location shift was used to assess superiority. Results: The median percentage change in WOMAC score at 6 months after injection for the high-dose, low-dose, and placebo groups was 83.9%, 51.5%, and 25.0%, respectively. The high- and low-dose groups had statistically significant changes in WOMAC scores when compared with the placebo group (high dose, P = .04; low dose, P = .02). The improvements were dose dependent. The median percentage change in WOMAC score from baseline to 1 year after injection for the high-dose, low-dose, and placebo groups was 89.5%, 68.2%, and 0%, respectively. The high- and low-dose groups displayed a greater percentage change at 12 months when compared with the placebo group (high dose, P = .006; low dose, P = .009). Magnetic resonance image review revealed no changes in cartilage thickness after treatment. No serious adverse events were reported. Conclusion: Intra-articular SVF injections can significantly decrease knee OA symptoms and pain for at least 12 months. The efficacy and safety demonstrated in this placebo-controlled trial support its implementation as a treatment option for symptomatic knee OA. Registration: NCT02726945 (ClinicalTrials.gov identifier)" @default.
• W3009013307 created "2020-03-06" @default.
• W3009013307 creator A5002597534 @default.
• W3009013307 creator A5043647557 @default.
• W3009013307 creator A5050134211 @default.
• W3009013307 creator A5061594042 @default.
• W3009013307 creator A5080636420 @default.
• W3009013307 creator A5083527172 @default.
• W3009013307 creator A5090986809 @default.
• W3009013307 date "2020-02-28" @default.
• W3009013307 modified "2023-10-14" @default.
• W3009013307 title "Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial" @default.
• W3009013307 cites W1983766143 @default.
• W3009013307 cites W2029927816 @default.
• W3009013307 cites W2053637639 @default.
• W3009013307 cites W2057180319 @default.
• W3009013307 cites W2068728378 @default.
• W3009013307 cites W2105355405 @default.
• W3009013307 cites W2116833500 @default.
• W3009013307 cites W2165797485 @default.
• W3009013307 cites W2267939095 @default.
• W3009013307 cites W2403298082 @default.
• W3009013307 cites W2417583032 @default.
• W3009013307 cites W2508922037 @default.
• W3009013307 cites W2587001350 @default.
• W3009013307 cites W2614933788 @default.
• W3009013307 cites W2616167388 @default.
• W3009013307 cites W2623617881 @default.
• W3009013307 cites W2625285338 @default.
• W3009013307 cites W2661440646 @default.
• W3009013307 cites W2747777164 @default.
• W3009013307 cites W2762078609 @default.
• W3009013307 cites W2885527831 @default.
• W3009013307 cites W2897706271 @default.
• W3009013307 cites W4238859033 @default.
• W3009013307 doi "https://doi.org/10.1177/0363546519899923" @default.
• W3009013307 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7137118" @default.
• W3009013307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32109160" @default.
• W3009013307 hasPublicationYear "2020" @default.
• W3009013307 type Work @default.
• W3009013307 sameAs 3009013307 @default.
• W3009013307 citedByCount "97" @default.
• W3009013307 countsByYear W30090133072020 @default.
• W3009013307 countsByYear W30090133072021 @default.
• W3009013307 countsByYear W30090133072022 @default.
• W3009013307 countsByYear W30090133072023 @default.
• W3009013307 crossrefType "journal-article" @default.
• W3009013307 hasAuthorship W3009013307A5002597534 @default.
• W3009013307 hasAuthorship W3009013307A5043647557 @default.
• W3009013307 hasAuthorship W3009013307A5050134211 @default.
• W3009013307 hasAuthorship W3009013307A5061594042 @default.
• W3009013307 hasAuthorship W3009013307A5080636420 @default.
• W3009013307 hasAuthorship W3009013307A5083527172 @default.
• W3009013307 hasAuthorship W3009013307A5090986809 @default.
• W3009013307 hasConcept C111278954 @default.
• W3009013307 hasConcept C126322002 @default.
• W3009013307 hasConcept C141071460 @default.
• W3009013307 hasConcept C142724271 @default.
• W3009013307 hasConcept C168563851 @default.
• W3009013307 hasConcept C171089720 @default.
• W3009013307 hasConcept C204787440 @default.
• W3009013307 hasConcept C27081682 @default.
• W3009013307 hasConcept C2776164576 @default.
• W3009013307 hasConcept C2779286237 @default.
• W3009013307 hasConcept C2780745355 @default.
• W3009013307 hasConcept C535046627 @default.
• W3009013307 hasConcept C71924100 @default.
• W3009013307 hasConceptScore W3009013307C111278954 @default.
• W3009013307 hasConceptScore W3009013307C126322002 @default.
• W3009013307 hasConceptScore W3009013307C141071460 @default.
• W3009013307 hasConceptScore W3009013307C142724271 @default.
• W3009013307 hasConceptScore W3009013307C168563851 @default.
• W3009013307 hasConceptScore W3009013307C171089720 @default.
• W3009013307 hasConceptScore W3009013307C204787440 @default.
• W3009013307 hasConceptScore W3009013307C27081682 @default.
• W3009013307 hasConceptScore W3009013307C2776164576 @default.
• W3009013307 hasConceptScore W3009013307C2779286237 @default.
• W3009013307 hasConceptScore W3009013307C2780745355 @default.
• W3009013307 hasConceptScore W3009013307C535046627 @default.
• W3009013307 hasConceptScore W3009013307C71924100 @default.
• W3009013307 hasIssue "3" @default.
• W3009013307 hasLocation W30090133071 @default.
• W3009013307 hasLocation W30090133072 @default.
• W3009013307 hasOpenAccess W3009013307 @default.
• W3009013307 hasPrimaryLocation W30090133071 @default.
• W3009013307 hasRelatedWork W1556335090 @default.
• W3009013307 hasRelatedWork W2089973119 @default.
• W3009013307 hasRelatedWork W2153862724 @default.
• W3009013307 hasRelatedWork W2287567982 @default.
• W3009013307 hasRelatedWork W2355198127 @default.
• W3009013307 hasRelatedWork W2781685565 @default.
• W3009013307 hasRelatedWork W2997307408 @default.
• W3009013307 hasRelatedWork W3108940874 @default.
• W3009013307 hasRelatedWork W3163259831 @default.
• W3009013307 hasRelatedWork W4254460683 @default.
• W3009013307 hasVolume "48" @default.
• W3009013307 isParatext "false" @default.
• W3009013307 isRetracted "false" @default.

• next